Akihiro Iida

Summary

Country: Japan

Publications

  1. ncbi request reprint [Development of a novel cytoplasmic RNA vector based on the reverse genetics of Sendai virus: a breakthrough to the cytoplasmic gene therapy]
    Akihiro Iida
    Tanpakushitsu Kakusan Koso 48:1371-7. 2003
  2. ncbi request reprint Cytoplasmic RNA vector derived from nontransmissible Sendai virus. Production and use
    Akihiro Iida
    DNAVEC Research Inc, Tsukuba shi, Ibaraki, Japan
    Methods Mol Med 69:361-70. 2002
  3. ncbi request reprint [Sendai virus vector: vector development and its application to health care and biotechnology]
    Akihiro Iida
    DNAVEC Corporation, 1 25 11 Kannondai, Tsukuba, Ibaraki 305 0856, Japan
    Uirusu 57:29-36. 2007
  4. ncbi request reprint [Development of Sendai virus vectors and their application to the fields of medical care and biotechnology]
    Akihiro Iida
    Tanpakushitsu Kakusan Koso 52:1274-80. 2007
  5. ncbi request reprint CFTR gene transfer to human cystic fibrosis pancreatic duct cells using a Sendai virus vector
    Zoltan Rakonczay
    Institute for Cell and Molecular Biosciences, University of Newcastle, Newcastle upon Tyne, United Kingdom
    J Cell Physiol 214:442-55. 2008
  6. ncbi request reprint Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity
    Mariko Yoshizaki
    DNAVEC Corporation, 1 25 11 Kannondai, Tsukuba shi, Ibaraki 305 0856, Japan
    J Gene Med 8:1151-9. 2006
  7. ncbi request reprint Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable properties
    Makoto Inoue
    DNAVEC Research Inc, 1 25 11 Kannondai, Tsukuba shi, Ibaraki 305 0856, Japan
    J Gene Med 6:1069-81. 2004
  8. ncbi request reprint [Sendai virus based vectors]
    Akihiro Iida
    DNAVEC Research Inc, 1 25 11 Kannondai, Tsukuba, Ibaraki 305 0856, Japan
    Uirusu 53:171-5. 2003
  9. pmc Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model
    Akiko Takeda
    Department of Microbiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113 0033, Japan
    J Virol 77:9710-5. 2003
  10. pmc A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading
    Makoto Inoue
    DNAVEC Research Inc, Tsukuba shi, Ibaraki 305 0856, Japan
    J Virol 77:6419-29. 2003

Collaborators

  • Yoshiyuki Nagai
  • Tetsuro Matano
  • Eric W F W Alton
  • U Griesenbach
  • Mamoru Hasegawa
  • Makoto Inoue
  • Takahiro Hirata
  • Yumiko Tokusumi
  • Hiroshi Ban
  • Tsuyoshi Tokusumi
  • Mariko Yoshizaki
  • Akiko Takeda
  • Takumi Kanaya
  • Chikaya Moriya
  • Zoltan Rakonczay
  • Takashi Hironaka
  • Moriaki Kato
  • Hiromi Nakamura
  • Hiroko Igarashi
  • Munehide Kano
  • Masayuki Shirakura
  • Masanori Kobayashi
  • Atsushi Kato
  • Barry E Argent
  • Tsugumine Shu
  • Peter Hegyi
  • Anil Mehta
  • Gabriella Ovári
  • Gabor Varga
  • Michael A Gray
  • Janos Lonovics
  • Hiroto Hara
  • Satoshi Horiba
  • Jun You
  • Russell M Crawford
  • Imre Ignáth
  • Ana C Da Paula
  • Margarida D Amaral
  • Janos Vag
  • Hitoshi Iwasaki
  • Shigeo Horie
  • Tetsutaro Sata
  • Eiji Higashihara
  • Yuri Sasaki
  • Yasuji Ueda
  • Takako Shiraki-Iida
  • Kaio Kitazato

Detail Information

Publications16

  1. ncbi request reprint [Development of a novel cytoplasmic RNA vector based on the reverse genetics of Sendai virus: a breakthrough to the cytoplasmic gene therapy]
    Akihiro Iida
    Tanpakushitsu Kakusan Koso 48:1371-7. 2003
  2. ncbi request reprint Cytoplasmic RNA vector derived from nontransmissible Sendai virus. Production and use
    Akihiro Iida
    DNAVEC Research Inc, Tsukuba shi, Ibaraki, Japan
    Methods Mol Med 69:361-70. 2002
  3. ncbi request reprint [Sendai virus vector: vector development and its application to health care and biotechnology]
    Akihiro Iida
    DNAVEC Corporation, 1 25 11 Kannondai, Tsukuba, Ibaraki 305 0856, Japan
    Uirusu 57:29-36. 2007
    ....
  4. ncbi request reprint [Development of Sendai virus vectors and their application to the fields of medical care and biotechnology]
    Akihiro Iida
    Tanpakushitsu Kakusan Koso 52:1274-80. 2007
  5. ncbi request reprint CFTR gene transfer to human cystic fibrosis pancreatic duct cells using a Sendai virus vector
    Zoltan Rakonczay
    Institute for Cell and Molecular Biosciences, University of Newcastle, Newcastle upon Tyne, United Kingdom
    J Cell Physiol 214:442-55. 2008
    ..Our data show that SeV vector is a potential CFTR gene transfer agent for human pancreatic duct cells and that expression of CFTR in CF cells is associated with a restoration of Cl- and HCO3- transport at the apical membrane...
  6. ncbi request reprint Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity
    Mariko Yoshizaki
    DNAVEC Corporation, 1 25 11 Kannondai, Tsukuba shi, Ibaraki 305 0856, Japan
    J Gene Med 8:1151-9. 2006
    ..We improved the vector by deleting all of the envelope-related genes from the SeV genome and thus reducing its immunogenicity...
  7. ncbi request reprint Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable properties
    Makoto Inoue
    DNAVEC Research Inc, 1 25 11 Kannondai, Tsukuba shi, Ibaraki 305 0856, Japan
    J Gene Med 6:1069-81. 2004
    ..In order to improve this vector, both the matrix (M) and fusion (F) genes were deleted from its genome...
  8. ncbi request reprint [Sendai virus based vectors]
    Akihiro Iida
    DNAVEC Research Inc, 1 25 11 Kannondai, Tsukuba, Ibaraki 305 0856, Japan
    Uirusu 53:171-5. 2003
  9. pmc Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model
    Akiko Takeda
    Department of Microbiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113 0033, Japan
    J Virol 77:9710-5. 2003
    ..6PD infections...
  10. pmc A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading
    Makoto Inoue
    DNAVEC Research Inc, Tsukuba shi, Ibaraki 305 0856, Japan
    J Virol 77:6419-29. 2003
    ..Thus, SeV/DeltaM is a novel type of vector with the characteristic features of loss of virus particle formation and gain of cell-to-cell spreading via a mechanism dependent on the activation of the fusion protein...
  11. pmc Nontransmissible virus-like particle formation by F-deficient sendai virus is temperature sensitive and reduced by mutations in M and HN proteins
    Makoto Inoue
    DNAVEC Research Inc, Tsukuba shi, Ibaraki 305 0856, Japan
    J Virol 77:3238-46. 2003
    ..The absence of F protein in SeV/deltaF and the additional mutations in M and HN in SeV/M(ts)HN(ts)deltaF probably weaken the ability to transport M protein to the plasma membrane, leading to the diminished formation of NTVLP...
  12. pmc Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus
    Masanori Kobayashi
    DNAVEC Research Inc, 1 25 11 Kannondai, Tsukuba, Ibaraki 305 0856, Japan
    J Virol 77:2607-14. 2003
    ..Therefore, SeV F- and HN-pseudotyped SIVagm vectors have considerable potential for effective use in gene therapy for various therapies, including respiratory diseases...
  13. ncbi request reprint An improved method for recovery of F-defective Sendai virus expressing foreign genes from cloned cDNA
    Takahiro Hirata
    DNAVEC Research Inc, 1 25 11 Kannondai, Tsukuba shi, Ibaraki 305 0856, Japan
    J Virol Methods 104:125-33. 2002
    ..This system may provide the basis for constructing recombinant F-defective Sendai virus for preventing and treating human diseases in the form of vaccines and vectors for gene therapy...
  14. ncbi request reprint Recombinant Sendai viruses expressing different levels of a foreign reporter gene
    Tsuyoshi Tokusumi
    DNAVEC Research Inc, Tsukuba shi, Ibaraki, Japan
    Virus Res 86:33-8. 2002
    ..This suggests the potential for matching therapeutic gene expression level to individual therapy programs by changing the position of the foreign gene when SeVs are used as vectors for human gene therapy...
  15. ncbi request reprint Induction of Gag-specific T-cell responses by therapeutic immunization with a Gag-expressing Sendai virus vector in macaques chronically infected with simian-human immunodeficiency virus
    Moriaki Kato
    Department of Microbiology, Graduate School of Medicine, The University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 0033, Japan
    Vaccine 23:3166-73. 2005
    ....
  16. doi request reprint Antigen-specific T-cell induction by vaccination with a recombinant Sendai virus vector even in the presence of vector-specific neutralizing antibodies in rhesus macaques
    Chikaya Moriya
    International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, 4 6 1 Shirokanedai, Minato ku, Tokyo 108 8639, Japan
    Biochem Biophys Res Commun 371:850-4. 2008
    ..This suggests the feasibility of inducing antigen-specific T-cell responses by SeV vaccination even in the host with pre-existing anti-SeV neutralizing antibodies...